Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Quarterly Syndicate Mid-point Forecasts

1 Apr 2021 07:00

RNS Number : 2127U
Helios Underwriting Plc
01 April 2021
Β 

1st April 2021

Β 

Helios Underwriting plc

('Helios' or 'the Company')

Β 

Quarterly Syndicate Mid-point Forecasts

Β 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2018 and 2019 years of account based on 4th quarter 2020 estimates.

Β 

Nigel Hanbury, Chief Executive, commented:

Β 

"As the only listed consolidator of private capital at Lloyd's, Helios offers a unique opportunity for growth and returns from exposure to the Lloyd's market through targeted acquisition of the capacity of the better quality syndicates. Our strategy is bringing results, with returns on average 5.7% better than the Lloyd's market itself over recent years.

Β 

"Following our recent successful fundraising, we are pursuing opportunities to further build our core portfolio of capacity, to increase the capacity retained by Helios and continue to achieve outperformance against the Lloyd's market as whole.

Β 

"We look forward to creating further shareholder value."

Β 

Β 

Year of Account

Β 

2018

2019

2020

2021

Β 

Β£m

Β£m

Β£m

Β£m

Capacity - Position as at 17th November 2020

Β 

Β 

Β 

Β 

Retained

27.6

23.3

21.1

Β 

Reinsured

38.2

39.0

49.1

Β 

Β 

65.8

62.2

70.2

Β 

Capacity acquired since 17th November 2020

Β 

Β 

Β 

Β 

Retained

8.5

8.0

9.7

Β 

Reinsured

-

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Capacity - Position as at 31st March 2021

Β 

Β 

Β 

Β 

Retained

36.1

31.3

30.8

58.6

Reinsured

38.2

39.0

49.1

51.6

Β 

74.3

70.3

80.0

110.3

Β 

Β 

Β 

Β 

Β 

Mid-point forecast at 30th September 2020

-2.10%

-2.60%

Β 

Β 

Final result / Current mid-point forecast

-0.30%

-2.15%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Lloyd's Market Average

-5.89%

-5.19%

Β 

Β 

Helios out performance

5.59%

3.04%

Β 

Β 

Β 

Commentary

Β 

The 2018 result showed a good improvement over the midpoint forecasts as at 30th September 2020 reflecting the investment returns achieved and the confidence in the old year reserves of the supported syndicates.

Β 

The outperformance of 5.6% of the portfolio against the average for the Lloyd's market for 2018 continues the trend of outperformance achieved over the last 6 years which averages over 5.7% over the period.

Β 

The smaller than expected improvement in 2019 midpoint forecast in the quarter reflects the continuing strengthening of the reserves for Covid 19 losses by syndicates.

Β 

Notes

1) The table above shows the capacity as at 31st March 2021 splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers.Β 

2) The acquisitions of the Limited Liability Vehicles and capacity acquired was announced on 2nd November 2020 and the acquisitions were completed on 27th November 2020.

3) The mid-point forecasts for 2018 and 2019 years of account as of 4th quarter 2020 have been aggregated at syndicate level from estimates supplied by Managing Agents.

4) The impact on Helios will be as follows:

a. The change in the mid point estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2020.

b. The overall change in the result will be recognised by Helios in cash at the close of the year of account.

Β 

For further information, please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive 07787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

Β 

Shore Capital Limited

Robert Finlay 020 7601 6100

David Coaten

Β 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

Quentin Perrot +44 (0)20 3124 6499 Β 

Β 

Buchanan

Helen Tarbet / Henry WilsonΒ / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

Β 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately Β£110m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCWPUUGWUPGGRG
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.